Biliranin

Biliranin may be available in the countries listed below.

Ingredient matches for Biliranin

Loratadine

Loratadine is reported as an ingredient of Biliranin in the following countries:

• Greece


• Oman

International Drug Name Search

Vetemucil

Vetemucil may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetemucil

Acetylcysteine

Acetylcysteine is reported as an ingredient of Vetemucil in the following countries:

• Italy

International Drug Name Search

D-Cort

D-Cort may be available in the countries listed below.

Ingredient matches for D-Cort

Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of D-Cort in the following countries:

• Bangladesh

International Drug Name Search

Coumadin

In the US, Coumadin (warfarin systemic) is a member of the drug class coumarins and indandiones and is used to treat Antiphospholipid Syndrome, Chronic Central Venous Catheterization, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis - First Event, Deep Vein Thrombosis - Recurrent Event, Heart Attack, Heart Failure, Prevention of Thromboembolism in Atrial Fibrillation, Prosthetic Heart Valves, Prosthetic Heart Valves - Mechanical Valves, Prosthetic Heart Valves - Tissue Valves, Protein S Deficiency, Pulmonary Embolism - First Event, Pulmonary Embolism - Recurrent Event and Thromboembolic Stroke Prophylaxis.

US matches:

• Coumadin


• Coumadin Tablets


• Coumadin Intravenous


• Coumadin Injection

Ingredient matches for Coumadin

Warfarin

Warfarin sodium salt (a derivative of Warfarin) is reported as an ingredient of Coumadin in the following countries:

• Argentina


• Australia


• Canada


• Chile


• Colombia


• Germany


• Israel


• Italy


• New Zealand


• Oman


• Peru


• Philippines


• Singapore


• Taiwan


• Turkey


• United States


• Venezuela

International Drug Name Search

Lexotan

Lexotan may be available in the countries listed below.

Ingredient matches for Lexotan

Bromazepam

Bromazepam is reported as an ingredient of Lexotan in the following countries:

• Argentina


• Aruba


• Australia


• Bahrain


• Belgium


• Benin


• Bolivia


• Botswana


• Brazil


• Bulgaria


• Cambodia


• Cameroon


• Chile


• Colombia


• Congo


• Cote D'ivoire


• Cyprus


• Denmark


• Ecuador


• Gabon


• Georgia


• Ghana


• Greece


• Guinea


• Hong Kong


• Iceland


• Indonesia


• Ireland


• Italy


• Jamaica


• Japan


• Jordan


• Kenya


• Kuwait


• Laos


• Lithuania


• Luxembourg


• Malawi


• Malaysia


• Mali


• Malta


• Mauritius


• Mexico


• Moldova


• Morocco


• Namibia


• Nigeria


• Oman


• Pakistan


• Paraguay


• Peru


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Singapore


• South Africa


• Sri Lanka


• Sudan


• Taiwan


• Tanzania


• Thailand


• Togo


• Trinidad & Tobago


• Uganda


• United Arab Emirates


• Uruguay


• Vietnam


• Zaire


• Zambia


• Zimbabwe

International Drug Name Search

Espin

Espin may be available in the countries listed below.

Ingredient matches for Espin

Dosulepin

Dosulepin hydrochloride (a derivative of Dosulepin) is reported as an ingredient of Espin in the following countries:

• Singapore

International Drug Name Search

Oxandrolone

In the US, Oxandrolone (oxandrolone systemic) is a member of the drug class androgens and anabolic steroids and is used to treat Alcoholic Liver Damage, Turner's Syndrome and Weight Loss.

US matches:

• Oxandrolone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A14AA08

CAS registry number (Chemical Abstracts Service)

0000053-39-4

Chemical Formula

C19-H30-O3

Molecular Weight

306

Therapeutic Categories

Anabolic

Androgen

Chemical Name

2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5α,17ß)-

Foreign Names

• Oxandrolonum (Latin)
• Oxandrolon (German)
• Oxandrolone (French)
• Oxandrolona (Spanish)

Generic Names

• Oxandrolone (OS: BAN, DCIT, DCF, JAN, USAN)
• CB 8075 (IS)
• Protivar (IS)
• SC 11585 (IS)
• Oxandrolone (PH: USP 32)

Brand Names

• Oxandrin
  Savient, United States



• Oxandrolone
  Kali, United States; Sandoz, United States; Upsher-Smith, United States; Watson, United States



• Xtendrol
  Atlantis, Mexico

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Recal D Chewable Wafers

Pronunciation: KAL-see-um KAR-bo-nate/VYE-ta-min D/VYE-ta-min B/FOE-lik AS-id
Generic Name: Calcium Carbonate/Vitamin D/Vitamin B6/Vitamin B12/Folic Acid
Brand Name: Examples include CalciFolic-D and Recal D

Keep Recal D Chewable Wafers out of the reach of children.

Recal D Chewable Wafers are used for:

Treating or preventing calcium deficiency, bone weakness, and osteoporosis in certain patients. It may also be used for other conditions as determined by your doctor.

Recal D Chewable Wafers are a dietary supplement. It works by providing extra calcium, certain vitamins, folic acid, and minerals to your body.

Do NOT use Recal D Chewable Wafers if:

• you are allergic to any ingredient in Recal D Chewable Wafers


• you have high blood calcium levels or pernicious anemia


• if you take levodopa or mycophenolate

Contact your doctor or health care provider right away if any of these apply to you.

Before using Recal D Chewable Wafers:

Some medical conditions may interact with Recal D Chewable Wafers. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you are dehydrated or have anemia, low vitamin B₁₂ levels, or high blood phosphate levels


• if you have heart problems, hardening of the arteries, kidney problems, or kidney stones

Some MEDICINES MAY INTERACT with Recal D Chewable Wafers. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Carbamazepine, hydantoins (eg, phenytoin), levodopa, mycophenolate, penicillamine, phenobarbital, or valproic acid because their effectiveness may be decreased by Recal D Chewable Wafers


• Fluorouracil or oral anticoagulants (eg, dicumarol) because the risk of their side effects may be increased by Recal D Chewable Wafers

This may not be a complete list of all interactions that may occur. Ask your health care provider if Recal D Chewable Wafers may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Recal D Chewable Wafers:

Use Recal D Chewable Wafers as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Recal D Chewable Wafers by mouth with or without food.


• Chew Recal D Chewable Wafers well before you swallow it.


• Take Recal D Chewable Wafers with a full glass of water (8 oz/240 mL).


• If you take an azole antifungal (eg, ketoconazole), a bisphosphonate (eg, alendronate), a cation exchange resin (eg, sodium polystyrene sulfonate), certain cephalosporins (eg, cefdinir), dabigatran, eltrombopag, penicillamine, a quinolone antibiotic (eg, ciprofloxacin), a tetracycline antibiotic (eg, doxycycline), or a thyroid hormone (eg, levothyroxine), ask your doctor or pharmacist how to take them with Recal D Chewable Wafers.


• If you miss a dose of Recal D Chewable Wafers, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Recal D Chewable Wafers.

Important safety information:

• Do not take large doses of vitamins while you use Recal D Chewable Wafers unless your doctor tells you to.


• Before you start any new medicine, check the label to see if it has any of the same ingredients that are found in Recal D Chewable Wafers. If it does or if you are not sure, check with your doctor or pharmacist.


• Recal D Chewable Wafers should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Recal D Chewable Wafers while you are pregnant. It is not known if Recal D Chewable Wafers are found in breast milk. If you are or will be breast-feeding while you use Recal D Chewable Wafers, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Recal D Chewable Wafers:

All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with Recal D Chewable Wafers. Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Recal D side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Recal D Chewable Wafers:

Store Recal D Chewable Wafers at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Recal D Chewable Wafers out of the reach of children and away from pets.

General information:

• If you have any questions about Recal D Chewable Wafers, please talk with your doctor, pharmacist, or other health care provider.


• Recal D Chewable Wafers are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Recal D Chewable Wafers. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Recal D resources

• Recal D Side Effects (in more detail)
• Recal D Use in Pregnancy & Breastfeeding
• Recal D Drug Interactions
• Recal D Support Group
• 0 Reviews for Recal D - Add your own review/rating

Compare Recal D with other medications

• Vitamin/Mineral Supplementation and Deficiency

Peptic Ulcer with Perforation Medications

Topics under Peptic Ulcer with Perforation

• Peptic Ulcer with Perforation and Obstruction (0 drugs)

Learn more about Peptic Ulcer with Perforation

Micromedex Care Notes:

• Peptic Ulcer

Medical Encyclopedia:

• Erosion
• Gastric ulcer
• Peptic ulcer

Drug List:

Dicloxal

Dicloxal may be available in the countries listed below.

Ingredient matches for Dicloxal

Dicloxacillin

Dicloxacillin sodium salt (a derivative of Dicloxacillin) is reported as an ingredient of Dicloxal in the following countries:

• Peru

Oxacillin

Oxacillin sodium (a derivative of Oxacillin) is reported as an ingredient of Dicloxal in the following countries:

• Peru

International Drug Name Search

Espercil

Espercil may be available in the countries listed below.

Ingredient matches for Espercil

Tranexamic Acid

Tranexamic Acid is reported as an ingredient of Espercil in the following countries:

• Chile

International Drug Name Search

Gluconato de Calcio Apolo

Gluconato de Calcio Apolo may be available in the countries listed below.

Ingredient matches for Gluconato de Calcio Apolo

Calcium Gluconate

Calcium Gluconate is reported as an ingredient of Gluconato de Calcio Apolo in the following countries:

• Argentina

International Drug Name Search

Aliaron F

Aliaron F may be available in the countries listed below.

Ingredient matches for Aliaron F

Fursultiamine

Fursultiamine is reported as an ingredient of Aliaron F in the following countries:

• Japan

International Drug Name Search

Cortisdin Urea

Cortisdin Urea may be available in the countries listed below.

Ingredient matches for Cortisdin Urea

Fluorometholone

Fluorometholone is reported as an ingredient of Cortisdin Urea in the following countries:

• Spain

Urea

Urea is reported as an ingredient of Cortisdin Urea in the following countries:

• Spain

International Drug Name Search

Propamide

Propamide may be available in the countries listed below.

Ingredient matches for Propamide

Chlorpropamide

Chlorpropamide is reported as an ingredient of Propamide in the following countries:

• Singapore

International Drug Name Search

Espironolactona Northia

Espironolactona Northia may be available in the countries listed below.

Ingredient matches for Espironolactona Northia

Spironolactone

Spironolactone is reported as an ingredient of Espironolactona Northia in the following countries:

• Argentina

International Drug Name Search

Naquasone

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Naquasone

Dexamethasone

Dexamethasone is reported as an ingredient of Naquasone in the following countries:

• Australia


• United States

Trichlormethiazide

Trichlormethiazide is reported as an ingredient of Naquasone in the following countries:

• Australia


• United States

International Drug Name Search

Esloric

Esloric may be available in the countries listed below.

Ingredient matches for Esloric

Allopurinol

Allopurinol is reported as an ingredient of Esloric in the following countries:

• Bangladesh

International Drug Name Search

Polcortolon TC

Polcortolon TC may be available in the countries listed below.

Ingredient matches for Polcortolon TC

Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Polcortolon TC in the following countries:

• Poland

Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Polcortolon TC in the following countries:

• Poland

International Drug Name Search

Etoposido

Etoposido may be available in the countries listed below.

Ingredient matches for Etoposido

Etoposide

Etoposide is reported as an ingredient of Etoposido in the following countries:

• Chile

International Drug Name Search

Delsym Nighttime Cough & Cold

Generic Name: acetaminophen, dextromethorphan, and doxylamine (a SEET a MIN oh fen, DEX tro me THOR fan, and dox IL a meen)

Brand Names: All-Nite, Coricidin HBP Nighttime Multi-Symptom Cold, Cough & Sore Throat Nighttime, Delsym Nighttime Cough & Cold, Multi-Symptom Nighttime Cold & Flu Relief, Multi-Symptom Nighttime Cold & Flu Relief (cherry), Night Time Cold/Flu, Nite Time Cold & Flu, Nite Time Cold & Flu Relief, Nyquil Cold & Flu, NyQuil Cold/Flu Relief, NyQuil Cold/Flu Relief Cherry, Tylenol Cold & Cough Nighttime Cool Burst, Tylenol Cough & Sore Throat Night Time, Tylenol Warming Cough & Sore Throat Nightime

What is Delsym Nighttime Cough & Cold (acetaminophen, dextromethorphan, and doxylamine)?

Acetaminophen is a pain reliever and fever reducer.

Doxylamine is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.

Dextromethorphan is a cough suppressant. It affects the cough reflex in the brain that triggers coughing.

The combination of acetaminophen, doxylamine, and dextromethorphan is used to treat headache, fever, body aches, cough, runny nose, sneezing, itching, and watery eyes caused by allergies, the common cold, or the flu.

This medicine will not treat a cough that is caused by smoking, asthma, or emphysema.

Acetaminophen, doxylamine, and dextromethorphan may also be used for purposes not listed in this medication guide.

What is the most important information I should know about this medicine?

Do not take more of this medication than is recommended. An overdose of acetaminophen can damage your liver or cause death. Do not take this medication without a doctor's advice if you have ever had alcoholic liver disease (cirrhosis) or if you drink more than 3 alcoholic beverages per day. You should not use this medicine if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use this medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Do not use this medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects. Avoid drinking alcohol. It may increase your risk of liver damage while you are taking acetaminophen, and can increase certain side effects of doxylamine. Ask a doctor or pharmacist before using any other cold, allergy, pain, or sleep medication. Acetaminophen (sometimes abbreviated as APAP) is contained in many combination medicines. Taking certain products together can cause you to get too much acetaminophen which can lead to a fatal overdose. Check the label to see if a medicine contains acetaminophen or APAP.

What should I discuss with my healthcare provider before taking this medicine?

You should not use this medicine if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use this medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Do not use this medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:

• 
  

  liver disease, cirrhosis, a history of alcoholism, or if you drink more than 3 alcoholic beverages per day;

  
  


• 
  

  a blockage in your digestive tract (stomach or intestines);

  
  


• 
  

  kidney disease;

  
  


• 
  

  cough with mucus, or cough caused by emphysema or chronic bronchitis;

  
  


• 
  

  enlarged prostate or urination problems; or

  
  


• 
  

  if you take potassium (Cytra, Epiklor, K-Lyte, K-Phos, Kaon, Klor-Con, Polycitra, Urocit-K).

  
  

It is not known whether acetaminophen, doxylamine, and dextromethorphan will harm an unborn baby. Do not use this medicine without a doctor's advice if you are pregnant. Acetaminophen, doxylamine, and dextromethorphan may pass into breast milk and may harm a nursing baby. Antihistamines may also slow breast milk production. Do not use this medicine without a doctor's advice if you are breast-feeding a baby.

Artificially sweetened cold medicine may contain phenylalanine. If you have phenylketonuria (PKU), check the medication label to see if the product contains phenylalanine.

How should I take this medicine?

Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. This medicine is usually taken only for a short time until your symptoms clear up.

Do not take more of this medication than is recommended. An overdose of acetaminophen can damage your liver or cause death. Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

Measure liquid medicine with a special dose measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose measuring device, ask your pharmacist for one.

Do not take for longer than 7 days in a row. Stop taking the medicine and call your doctor if you still have a fever after 3 days of use, you still have pain after 7 days (or 5 days if treating a child), if your symptoms get worse, or if you have a skin rash, ongoing headache, or any redness or swelling.

If you need surgery or medical tests, tell the surgeon or doctor ahead of time if you have taken this medicine within the past few days. Store at room temperature away from moisture and heat. Do not allow liquid medicine to freeze.

What happens if I miss a dose?

Since this medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of acetaminophen can be fatal.

The first signs of an acetaminophen overdose include loss of appetite, nausea, vomiting, stomach pain, sweating, and confusion or weakness. Later symptoms may include pain in your upper stomach, dark urine, and yellowing of your skin or the whites of your eyes.

Overdose symptoms may also include severe forms of some of the side effects listed in this medication guide.

What should I avoid while taking this medicine?

Ask a doctor or pharmacist before using any other cold, allergy, pain, or sleep medication. Acetaminophen (sometimes abbreviated as APAP) is contained in many combination medicines. Taking certain products together can cause you to get too much acetaminophen which can lead to a fatal overdose. Check the label to see if a medicine contains acetaminophen or APAP. Avoid drinking alcohol. It may increase your risk of liver damage while you are taking acetaminophen, and can increase certain side effects of doxylamine. This medicine may cause blurred vision or impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly.

This medicine side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have a serious side effect such as:

• 
  

  chest pain, rapid pulse;

  
  


• 
  

  fast, slow, or uneven heart rate;

  
  


• 
  

  severe dizziness or anxiety, feeling like you might pass out;

  
  


• 
  

  severe headache;

  
  


• 
  

  mood changes, confusion, hallucinations, severe nervousness;

  
  


• 
  

  tremor, seizure (convulsions);

  
  


• 
  

  fever, easy bruising or bleeding, unusual weakness;

  
  


• 
  

  urinating less than usual or not at all;

  
  


• 
  

  nausea, pain in your upper stomach, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of your skin or eyes); or

  
  


• 
  

  dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, chest pain, uneven heartbeats, seizure).

  
  

Less serious side effects may include:

• 
  

  dizziness, drowsiness, mild headache;

  
  


• 
  

  dry mouth, nose, or throat;

  
  


• 
  

  constipation, diarrhea, mild nausea, upset stomach;

  
  


• 
  

  blurred vision;

  
  


• 
  

  feeling restless or irritable; or

  
  


• 
  

  sleep problems (insomnia).

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect this medicine?

Ask a doctor or pharmacist before using this medicine if you regularly use other medicines that make you sleepy (such as narcotic pain medication, sedatives, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by doxylamine.

Ask a doctor or pharmacist if it is safe for you to use acetaminophen, doxylamine, and dextromethorphan if you are also using any of the following drugs:

• 
  

  leflunomide (Arava);

  
  


• 
  

  topiramate (Topamax);

  
  


• 
  

  zonisamide (Zonegran);

  
  


• 
  

  an antibiotic, antifungal medicine, sulfa drug, or tuberculosis medicine;

  
  


• 
  

  an antidepressant;

  
  


• 
  

  birth control pills or hormone replacement therapy;

  
  


• 
  

  bladder or urinary medications;

  
  


• 
  

  blood pressure medication;

  
  


• 
  

  a bronchodilator;

  
  


• 
  

  cancer medicine;

  
  


• 
  

  cholesterol-lowering medications such as Lipitor, Niaspan, Zocor, Vytorin, and others;

  
  


• 
  

  gout or arthritis medications (including gold injections);

  
  


• 
  

  HIV/AIDS medication;

  
  


• 
  

  medication for nausea and vomiting, stomach ulcers, or irritable bowel syndrome;

  
  


• 
  

  medicines to treat psychiatric disorders;

  
  


• 
  

  an NSAID such as Advil, Aleve, Arthrotec, Cataflam, Celebrex, Indocin, Motrin, Naprosyn, Treximet, Voltaren, others; or

  
  


• 
  

  seizure medication.

  
  

This list is not complete and there may be other drugs that can affect acetaminophen, dextromethorphan, and doxylamine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

More Delsym Nighttime Cough & Cold resources

• Delsym Nighttime Cough & Cold Use in Pregnancy & Breastfeeding
• Delsym Nighttime Cough & Cold Drug Interactions
• 0 Reviews for Delsym Nighttime Cough & Cold - Add your own review/rating

Compare Delsym Nighttime Cough & Cold with other medications

• Cough
• Pain

Where can I get more information?

• Your pharmacist can provide more information about acetaminophen, dextromethorphan, and doxylamine.

Klaribac

Klaribac may be available in the countries listed below.

Ingredient matches for Klaribac

Clarithromycin

Clarithromycin is reported as an ingredient of Klaribac in the following countries:

• Bahrain


• Iraq


• Jordan


• Kuwait


• Lebanon


• Libya


• Nigeria


• Oman


• Qatar


• Saudi Arabia


• Sudan


• Syria


• Tunisia


• United Arab Emirates


• Yemen

International Drug Name Search

Endiex

Endiex may be available in the countries listed below.

Ingredient matches for Endiex

Nifuroxazide

Nifuroxazide is reported as an ingredient of Endiex in the following countries:

• Slovakia

International Drug Name Search

Cifox

Cifox may be available in the countries listed below.

Ingredient matches for Cifox

Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Cifox in the following countries:

• Ireland

International Drug Name Search

Esdelart

Esdelart may be available in the countries listed below.

Ingredient matches for Esdelart

Danazol

Danazol is reported as an ingredient of Esdelart in the following countries:

• Japan

International Drug Name Search

Rifamycine

Rifamycine may be available in the countries listed below.

Ingredient matches for Rifamycine

Rifamycin

Rifamycine (DCF) is also known as Rifamycin (Rec.INN)

Rifampicin

Rifampicin is reported as an ingredient of Rifamycine in the following countries:

• Ethiopia

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Disopyramide Jadran

Disopyramide Jadran may be available in the countries listed below.

Ingredient matches for Disopyramide Jadran

Disopyramide

Disopyramide is reported as an ingredient of Disopyramide Jadran in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

DF 118

DF-118 may be available in the countries listed below.

Ingredient matches for DF-118

Dihydrocodeine

Dihydrocodeine tartrate (a derivative of Dihydrocodeine) is reported as an ingredient of DF-118 in the following countries:

• Hong Kong


• Ireland


• Malaysia


• South Africa


• United Kingdom

International Drug Name Search

Cisplatin-Lens

Cisplatin-Lens may be available in the countries listed below.

Ingredient matches for Cisplatin-Lens

Cisplatin

Cisplatin is reported as an ingredient of Cisplatin-Lens in the following countries:

• Georgia

International Drug Name Search

Cal-De-Granulat

Cal-De-Granulat may be available in the countries listed below.

Ingredient matches for Cal-De-Granulat

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Cal-De-Granulat in the following countries:

• Austria

Colecalciferol

Colecalciferol is reported as an ingredient of Cal-De-Granulat in the following countries:

• Austria

International Drug Name Search

Meglumina

Meglumina may be available in the countries listed below.

Ingredient matches for Meglumina

Meglumine

Meglumina (DCIT) is also known as Meglumine (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ecofenac

Ecofenac may be available in the countries listed below.

Ingredient matches for Ecofenac

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Ecofenac in the following countries:

• Switzerland

International Drug Name Search

Ketorolaco Marfan

Ketorolaco Marfan may be available in the countries listed below.

Ingredient matches for Ketorolaco Marfan

Ketorolac

Ketorolac is reported as an ingredient of Ketorolaco Marfan in the following countries:

• Peru

International Drug Name Search

Tobramycin Sulphate

Tobramycin Sulphate may be available in the countries listed below.

Ingredient matches for Tobramycin Sulphate

Tobramycin

Tobramycin Sulphate (BANM) is known as Tobramycin in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Zafiron

Zafiron may be available in the countries listed below.

Ingredient matches for Zafiron

Formoterol

Formoterol fumarate dihydrate (a derivative of Formoterol) is reported as an ingredient of Zafiron in the following countries:

• Poland

International Drug Name Search

Vfend

Vfend is a brand name of voriconazole, approved by the FDA in the following formulation(s):

VFEND (voriconazole - for suspension; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: December 19, 2003
  
  Strength(s): 200MG/5ML ^[RLD]

VFEND (voriconazole - injectable; iv (infusion))

• 
  Manufacturer: PFIZER
  
  Approval date: May 24, 2002
  
  Strength(s): 200MG/VIAL ^[RLD]

VFEND (voriconazole - tablet; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: May 24, 2002
  
  Strength(s): 200MG ^[RLD][AB], 50MG ^[AB]

Has a generic version of Vfend been approved?

A generic version of Vfend has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Vfend and have been approved by the FDA:

voriconazole tablet; oral

• 
  Manufacturer: MATRIX LABS LTD
  
  Approval date: April 22, 2010
  
  Strength(s): 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: SANDOZ INC
  
  Approval date: December 12, 2011
  
  Strength(s): 200MG ^[AB], 50MG ^[AB]

Note: No generic formulation of the following products are available.

• voriconazole - for suspension; oral


• voriconazole - injectable; iv (infusion)

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vfend. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Triazole antifungal agents
  Patent 5,364,938
  Issued: November 15, 1994
  Inventor(s): Dickinson; Roger P. & Richardson; Kenneth
  Assignee(s): Pfizer Inc.
  The invention provides antifungal agents of the formula: ##STR1## and their pharmaceutically acceptable salts, wherein R is phenyl optionally substituted by 1 to 3 substituents each independently selected from halo and CF.sub.3 ; R.sup.1 is C.sub.1 -C.sub.4 alkyl; R.sup.2 is H or C.sub.1 -C.sub.4 alkyl; and "Het", which is attached to the adjacent carbon atom by a ring carbon atom, is selected from pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl and triazinyl, "Het" being optionally substituted by C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, halo, CF.sub.3, CN, NO.sub.2, NH.sub.2, --NH(C.sub.1 -C.sub.4 alkanoyl) or --NHCO.sub.2 (C.sub.1 -C.sub.4 alkyl).
  
  Patent expiration dates:
  
  
  • November 15, 2011
    
    ✓ 
    Drug substance
  
  



• 
  Triazole antifungal agents
  Patent 5,567,817
  Issued: October 22, 1996
  Inventor(s): Ray; Stephen J. & Richardson; Kenneth
  Assignee(s): Pfizer Inc.
  The invention provides antifungal compounds of the formula: ##STR1## and pharmaceutical salts thereof, wherein R is phenyl substituted by 1 to 3 substituents each independently selected from halo, --CF.sub.3 and --OCF.sub.3 ; R.sup.1 is C.sub.1 -C.sub.4 alkyl; R.sup.2 is H or C.sub.1 -C.sub.4 alkyl; X is CH or N; and Y is F or Cl.
  
  Patent expiration dates:
  
  
  • May 24, 2016
    
    ✓ 
    Patent use: TREATMENT OF FUNGAL INFECTIONS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Pharmaceutical formulations containing voriconazole
  Patent 6,632,803
  Issued: October 14, 2003
  Inventor(s): Valerie Denise; Harding
  Assignee(s): Pfizer Inc
  The invention provides pharmaceutical formulation comprising voriconazole, or a pharmaceutically acceptable derivative thereof, and a sulfobutylether &bgr;-cyclodextrin.
  
  Patent expiration dates:
  
  
  • June 2, 2018
    
    ✓ 
    Drug product
  
  

See also...

• Vfend Consumer Information (Drugs.com)
• Vfend Consumer Information (Wolters Kluwer)
• Vfend Suspension Consumer Information (Wolters Kluwer)
• Vfend Tablets Consumer Information (Wolters Kluwer)
• VFEND Consumer Information (Cerner Multum)
• Vfend Advanced Consumer Information (Micromedex)
• Vfend Oral Advanced Consumer Information (Micromedex)
• Vfend AHFS DI Monographs (ASHP)
• Voriconazole Consumer Information (Wolters Kluwer)
• Voriconazole Suspension Consumer Information (Wolters Kluwer)
• Voriconazole Tablets Consumer Information (Wolters Kluwer)
• Voriconazole Consumer Information (Cerner Multum)
• Vfend I.V. Advanced Consumer Information (Micromedex)
• Voriconazole Advanced Consumer Information (Micromedex)
• Voriconazole Oral, Intravenous Advanced Consumer Information (Micromedex)
• Voriconazole AHFS DI Monographs (ASHP)

Ferrofumaraat Sandoz

Ferrofumaraat Sandoz may be available in the countries listed below.

Ingredient matches for Ferrofumaraat Sandoz

Ferrous Fumarate

Ferrous Fumarate is reported as an ingredient of Ferrofumaraat Sandoz in the following countries:

• Netherlands

International Drug Name Search

Pinex

Pinex may be available in the countries listed below.

Ingredient matches for Pinex

Paracetamol

Paracetamol is reported as an ingredient of Pinex in the following countries:

• Denmark


• Norway

International Drug Name Search

Noscapine Hydrochloride

Noscapine Hydrochloride may be available in the countries listed below.

Ingredient matches for Noscapine Hydrochloride

Noscapine

Noscapine Hydrochloride (BANM, JAN) is also known as Noscapine (Rec.INN)

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Bio-Metronidazole

Bio-Metronidazole may be available in the countries listed below.

Ingredient matches for Bio-Metronidazole

Metronidazole

Metronidazole is reported as an ingredient of Bio-Metronidazole in the following countries:

• South Africa

International Drug Name Search

Be-Tabs Pyridoxine HCl

Be-Tabs Pyridoxine HCl may be available in the countries listed below.

Ingredient matches for Be-Tabs Pyridoxine HCl

Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Be-Tabs Pyridoxine HCl in the following countries:

• South Africa

International Drug Name Search

Glivec

Glivec may be available in the countries listed below.

UK matches:

• GLIVEC Tablets (SPC)

Ingredient matches for Glivec

Imatinib

Imatinib is reported as an ingredient of Glivec in the following countries:

• Tunisia


• Turkey

Imatinib mesilate (a derivative of Imatinib) is reported as an ingredient of Glivec in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Bangladesh


• Belgium


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• Finland


• France


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Taiwan


• Thailand


• United Kingdom


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Nimesulide Actavis

Nimesulide Actavis may be available in the countries listed below.

Ingredient matches for Nimesulide Actavis

Nimesulide

Nimesulide is reported as an ingredient of Nimesulide Actavis in the following countries:

• Italy

International Drug Name Search

Labetalol Hydrochloride

Ingredient matches for Labetalol Hydrochloride

Labetalol

Labetalol Hydrochloride (BANM, JAN, USAN) is known as Labetalol in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
JAN	Japanese Accepted Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Videne

Videne may be available in the countries listed below.

Ingredient matches for Videne

Povidone Iodine

Povidone-Iodine is reported as an ingredient of Videne in the following countries:

• Hong Kong


• United Kingdom

International Drug Name Search

Cervagème

Cervagème may be available in the countries listed below.

Ingredient matches for Cervagème

Gemeprost

Gemeprost is reported as an ingredient of Cervagème in the following countries:

• France

International Drug Name Search

Endo+Lint

Endo+Lint may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Endo+Lint

Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Endo+Lint in the following countries:

• South Africa

Praziquantel

Praziquantel is reported as an ingredient of Endo+Lint in the following countries:

• South Africa

International Drug Name Search

Mirtazapina Ratiomed

Mirtazapina Ratiomed may be available in the countries listed below.

Ingredient matches for Mirtazapina Ratiomed

Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapina Ratiomed in the following countries:

• Spain

International Drug Name Search

Nespo

Nespo may be available in the countries listed below.

Ingredient matches for Nespo

Darbepoetin Alfa

Darbepoetin Alfa is reported as an ingredient of Nespo in the following countries:

• Italy


• Slovakia

International Drug Name Search

Tofalcone

Tofalcone may be available in the countries listed below.

Ingredient matches for Tofalcone

Sofalcone

Sofalcone is reported as an ingredient of Tofalcone in the following countries:

• Japan

International Drug Name Search

Séléphos

Séléphos may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Séléphos

Sodium Selenite

Sodium Selenite is reported as an ingredient of Séléphos in the following countries:

• France

Tocopherol, α-

Tocopherol, α- acetate (a derivative of Tocopherol, α-) is reported as an ingredient of Séléphos in the following countries:

• France

International Drug Name Search

Valproate de sodium Arrow

Valproate de sodium Arrow may be available in the countries listed below.

Ingredient matches for Valproate de sodium Arrow

Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valproate de sodium Arrow in the following countries:

• France

International Drug Name Search

Enalapril / Hydrochloorthiazide Katwijk

Enalapril / Hydrochloorthiazide Katwijk may be available in the countries listed below.

Ingredient matches for Enalapril / Hydrochloorthiazide Katwijk

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril / Hydrochloorthiazide Katwijk in the following countries:

• Netherlands

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Enalapril / Hydrochloorthiazide Katwijk in the following countries:

• Netherlands

International Drug Name Search

Ecasolv

Ecasolv may be available in the countries listed below.

Ingredient matches for Ecasolv

Heparin

Heparin calcium salt (a derivative of Heparin) is reported as an ingredient of Ecasolv in the following countries:

• Italy

International Drug Name Search

Novoter Gentamicina

Novoter Gentamicina may be available in the countries listed below.

Ingredient matches for Novoter Gentamicina

Fluocinonide

Fluocinonide is reported as an ingredient of Novoter Gentamicina in the following countries:

• Spain

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Novoter Gentamicina in the following countries:

• Spain

International Drug Name Search

Eseridine

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0025573-43-7

Chemical Formula

C15-H21-N3-O3

Molecular Weight

291

Therapeutic Category

Parasympathomimetic agent, cholinesterase inhibitor

Chemical Name

(4aS,9aS)-2,3,4,4a,9,9a-Hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-yl methylcarbamate

Foreign Names

• Eseridinum (Latin)
• Eseridin (German)
• Éséridine (French)
• Eseridina (Spanish)

Generic Names

• Éséridine (OS: DCF)
• Eserine oxide (IS)
• Physostigmine Salicylate (OS: BAN, JAN, BANM)

Brand Names

• Féligastryl (veterinary use)
  Ceva, France



• Félipurgatyl (veterinary use)
  Laboratoire TVM, France



• Génésérine
  Eisai, France



• Pilocat (veterinary use)
  Omega Pharma France, France

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Velmetia

Velmetia may be available in the countries listed below.

Ingredient matches for Velmetia

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Velmetia in the following countries:

• Austria


• Germany


• Spain


• Switzerland

Sitagliptin

Sitagliptin phosphate hydrate (a derivative of Sitagliptin) is reported as an ingredient of Velmetia in the following countries:

• Austria


• Germany


• Spain


• Switzerland

International Drug Name Search

Nycoflox

Nycoflox may be available in the countries listed below.

Ingredient matches for Nycoflox

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Nycoflox in the following countries:

• Estonia


• Lithuania

International Drug Name Search

Calcium D3 Stada

Calcium D3 Stada may be available in the countries listed below.

Ingredient matches for Calcium D3 Stada

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calcium D3 Stada in the following countries:

• Germany

Colecalciferol

Colecalciferol is reported as an ingredient of Calcium D3 Stada in the following countries:

• Germany

International Drug Name Search

Edimox

Edimox may be available in the countries listed below.

Ingredient matches for Edimox

Acetazolamide

Acetazolamide is reported as an ingredient of Edimox in the following countries:

• Bangladesh

International Drug Name Search

Ansilive

Ansilive may be available in the countries listed below.

Ingredient matches for Ansilive

Diazepam

Diazepam is reported as an ingredient of Ansilive in the following countries:

• Brazil

International Drug Name Search

Flurbiprofène

Flurbiprofène may be available in the countries listed below.

Ingredient matches for Flurbiprofène

Flurbiprofen

Flurbiprofène (DCF) is known as Flurbiprofen in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Alvenor

Alvenor may be available in the countries listed below.

Ingredient matches for Alvenor

Diosmin

Diosmin is reported as an ingredient of Alvenor in the following countries:

• China

Hesperidin

Hesperidin is reported as an ingredient of Alvenor in the following countries:

• China

International Drug Name Search

Enalapril 1A Farma

Enalapril 1A Farma may be available in the countries listed below.

Ingredient matches for Enalapril 1A Farma

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril 1A Farma in the following countries:

• Denmark

International Drug Name Search

Simvastatin KSK

Simvastatin KSK may be available in the countries listed below.

Ingredient matches for Simvastatin KSK

Simvastatin

Simvastatin is reported as an ingredient of Simvastatin KSK in the following countries:

• Germany

International Drug Name Search

Betacorton

Betacorton may be available in the countries listed below.

Ingredient matches for Betacorton

Halcinonide

Halcinonide is reported as an ingredient of Betacorton in the following countries:

• Czech Republic


• Estonia


• Latvia


• Lithuania


• Slovakia


• Switzerland

Urea

Urea is reported as an ingredient of Betacorton in the following countries:

• Switzerland

International Drug Name Search

Ticlopidin Ratiopharm

Ticlopidin-ratiopharm may be available in the countries listed below.

Ingredient matches for Ticlopidin-ratiopharm

Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Ticlopidin-ratiopharm in the following countries:

• Belgium


• Czech Republic


• Germany


• Slovakia

International Drug Name Search

Apo-Chlorpropamide

Apo-Chlorpropamide may be available in the countries listed below.

Ingredient matches for Apo-Chlorpropamide

Chlorpropamide

Chlorpropamide is reported as an ingredient of Apo-Chlorpropamide in the following countries:

• Canada


• Vietnam

International Drug Name Search

Viracept

Viracept is a brand name of nelfinavir, approved by the FDA in the following formulation(s):

VIRACEPT (nelfinavir mesylate - powder; oral)

• 
  Manufacturer: AGOURON
  
  Approval date: March 14, 1997
  
  Strength(s): EQ 50MG BASE/SCOOPFUL ^[RLD]

VIRACEPT (nelfinavir mesylate - tablet; oral)

• 
  Manufacturer: AGOURON
  
  Approval date: March 14, 1997
  
  Strength(s): EQ 250MG BASE ^[RLD]


• 
  Manufacturer: AGOURON
  
  Approval date: April 30, 2003
  
  Strength(s): EQ 625MG BASE ^[RLD]

Has a generic version of Viracept been approved?

No. There is currently no therapeutically equivalent version of Viracept available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Viracept. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  HIV protease inhibitors
  Patent 5,484,926
  Issued: January 16, 1996
  Inventor(s): Dressman; Bruce A. & Fritz; James E. & Hammond; Marlys & Hornback; William J. & Kaldor; Stephen W. & Kalish; Vincent J. & Munroe; John E. & Reich; Siegfried H. & Tatlock; John H. & Shepherd; Timothy A. & Rodriguez; Michael J.
  Assignee(s): Agouron Pharmaceuticals, Inc.
  HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
  
  Patent expiration dates:
  
  
  • October 7, 2013
    
  
  
  
  • April 7, 2014
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  HIV protease inhibitors
  Patent 5,952,343
  Issued: September 14, 1999
  Inventor(s): Dressman; Bruce A. & Fritz; James E. & Hornback; William J. & Kaldor; Stephen W. & Kalish; Vincent J. & Munroe; John E. & Reich; Siegfried Heinz & Tatlock; John H. & Shepherd; Timothy A. & Rodriguez; Michael J.
  Assignee(s): Agouron Pharmaceuticals, Inc.
  HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
  
  Patent expiration dates:
  
  
  • October 7, 2013
    
    ✓ 
    Patent use: TREATMENT OF HIV INFECTION
  
  
  
  • April 7, 2014
    
    ✓ 
    Patent use: TREATMENT OF HIV INFECTION
    ✓ 
    Pediatric exclusivity
  
  



• 
  Pharmaceutical compositions containing HIV protease inhibitors and methods of their use
  Patent 6,162,812
  Issued: December 19, 2000
  Inventor(s): Dressman; Bruce A. & Fritz; James E. & Hammond; Marlys & Hornback; William J. & Kaldor; Stephen W. & Kalish; Vincent J. & Munroe; John E. & Reich; Siegfried Heinz & Tatlock; John H. & Shepherd; Timothy A. & Rodriguez; Michael J.
  Assignee(s): Agouron Pharmaceuticals, Inc.
  HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optically other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
  
  Patent expiration dates:
  
  
  • October 7, 2013
    
    ✓ 
    Patent use: TREATMENT OF HIV
  
  
  
  • April 7, 2014
    
    ✓ 
    Patent use: TREATMENT OF HIV
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Viracept Consumer Information (Drugs.com)
• Viracept Consumer Information (Wolters Kluwer)
• Viracept Powder Consumer Information (Wolters Kluwer)
• Viracept Consumer Information (Cerner Multum)
• Viracept Advanced Consumer Information (Micromedex)
• Viracept AHFS DI Monographs (ASHP)
• Nelfinavir Consumer Information (Wolters Kluwer)
• Nelfinavir Powder Consumer Information (Wolters Kluwer)
• Nelfinavir Consumer Information (Cerner Multum)
• Nelfinavir Advanced Consumer Information (Micromedex)
• Nelfinavir Mesylate AHFS DI Monographs (ASHP)

Nortin

Nortin may be available in the countries listed below.

Ingredient matches for Nortin

Nortriptyline

Nortriptyline hydrochloride (a derivative of Nortriptyline) is reported as an ingredient of Nortin in the following countries:

• Bangladesh

International Drug Name Search

Rhinostop

Rhinostop may be available in the countries listed below.

Ingredient matches for Rhinostop

Xylometazoline

Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Rhinostop in the following countries:

• Russian Federation


• Switzerland

International Drug Name Search

Eto-GRY

Eto-GRY may be available in the countries listed below.

Ingredient matches for Eto-GRY

Etoposide

Etoposide is reported as an ingredient of Eto-GRY in the following countries:

• Germany

International Drug Name Search

Esotrax

Esotrax may be available in the countries listed below.

Ingredient matches for Esotrax

Esomeprazole

Esomeprazole is reported as an ingredient of Esotrax in the following countries:

• India

International Drug Name Search

Lobeline Harvest Pharm

Lobeline Harvest Pharm may be available in the countries listed below.

Ingredient matches for Lobeline Harvest Pharm

Lobeline

Lobeline hydrochloride (a derivative of Lobeline) is reported as an ingredient of Lobeline Harvest Pharm in the following countries:

• China

International Drug Name Search

Betametasone Dipropionato Ecobi

Betametasone Dipropionato Ecobi may be available in the countries listed below.

Ingredient matches for Betametasone Dipropionato Ecobi

Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Betametasone Dipropionato Ecobi in the following countries:

• Italy

International Drug Name Search

Perebron

Perebron may be available in the countries listed below.

Ingredient matches for Perebron

Oxolamine

Oxolamine citrate (a derivative of Oxolamine) is reported as an ingredient of Perebron in the following countries:

• Chile


• Venezuela

Oxolamine phosphate (a derivative of Oxolamine) is reported as an ingredient of Perebron in the following countries:

• Chile


• Turkey


• Venezuela

International Drug Name Search

Efaxin

Efaxin may be available in the countries listed below.

Ingredient matches for Efaxin

Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Efaxin in the following countries:

• Greece

International Drug Name Search

Efferalgan pédiatrique

Efferalgan pédiatrique may be available in the countries listed below.

Ingredient matches for Efferalgan pédiatrique

Paracetamol

Paracetamol is reported as an ingredient of Efferalgan pédiatrique in the following countries:

• France

International Drug Name Search

Feldene

Feldene is a brand name of piroxicam, approved by the FDA in the following formulation(s):

FELDENE (piroxicam - capsule; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: April 6, 1982
  
  Strength(s): 10MG ^[AB], 20MG ^[RLD][AB]

Has a generic version of Feldene been approved?

Yes. The following products are equivalent to Feldene:

piroxicam capsule; oral

• 
  Manufacturer: MUTUAL PHARM
  
  Approval date: March 12, 1993
  
  Strength(s): 10MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: July 31, 1992
  
  Strength(s): 10MG ^[AB], 20MG ^[AB]


• 
  Manufacturer: NOSTRUM LABS
  
  Approval date: June 15, 1993
  
  Strength(s): 10MG ^[AB], 20MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: December 11, 1992
  
  Strength(s): 10MG ^[AB], 20MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: September 29, 1995
  
  Strength(s): 10MG ^[AB], 20MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: May 16, 1996
  
  Strength(s): 10MG ^[AB], 20MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Feldene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Feldene.

See also...

• Feldene Consumer Information (Wolters Kluwer)
• Feldene Consumer Information (Cerner Multum)
• Feldene Advanced Consumer Information (Micromedex)
• Feldene AHFS DI Monographs (ASHP)
• Piroxicam Consumer Information (Wolters Kluwer)
• Piroxicam Consumer Information (Cerner Multum)
• Alti-Piroxicam Advanced Consumer Information (Micromedex)
• Piroxicam Advanced Consumer Information (Micromedex)
• Piroxicam AHFS DI Monographs (ASHP)

Desamix Neomicina

Desamix Neomicina may be available in the countries listed below.

Ingredient matches for Desamix Neomicina

Dexamethasone

Dexamethasone is reported as an ingredient of Desamix Neomicina in the following countries:

• Italy

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Desamix Neomicina in the following countries:

• Italy

International Drug Name Search